Cost-utility analysis of treatment of chronic paediatric hepatitis C with new direct-acting antivirals [abstract 1619] | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Cost-utility analysis of treatment of chronic paediatric hepatitis C with new direct-acting antivirals [abstract 1619]

Greenway E, Haines A, Ling SC, et al. Cost-utility analysis of treatment of chronic paediatric hepatitis C with new direct-acting antivirals [abstract 1619]. The Liver Meeting 2019. Boston, Massachusetts; 2019.

Publication Type:

Conference Proceedings

Authors:

Greenway, E; Haines, A; Ling, SC; et, al

Source:

The Liver Meeting 2019, Boston, Massachusetts (2019)

Cited On:

HCV in Children

Export Citation:

RIS Format

Top